阿斯科隆抗生素是一种有前途的三类药物,用于纳格纳
Keisuke Suganuma1, Kennedy M Mochabo, Judith K Chemuliti
1National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro. k.suganuma@obihiro.ac.jp.
The Onderstepoort journal of veterinary research
|March 1, 2024
概括
阿斯科隆有效地清除了牛中的Trypanosoma vivax,但对Trypanosoma congolense的影响较小. 这项研究强调了ascofuranone.
科学领域:
- 兽医寄生虫学 兽医寄生虫学
- 药物发现 药物发现 药物发现
- 热带疾病 热带疾病
背景情况:
- 在撒哈拉以南非洲普遍存在的动物试索索症对牲畜构成重大威胁.
- 目前的类药物因药物耐药性普遍存在而面临挑战.
- 迫切需要替代治疗策略,以有效管理疾病.
研究的目的:
- 为了评估阿斯科龙 (AF) 作为潜在的三类药物的疗效.
- 评估AF对牛中的Trypanosoma vivax和Trypanosoma congolense的有效性.
主要方法:
- 六只雄性牛犊被分为两个组:T. vivax和T. congolense.
- 受感染的小牛可以通过肌肉注射接受阿斯科 (25毫克/公斤) 或安慰剂 (PBS).
- 监测了寄生病水平,以评估治疗的疗效.
主要成果:
- 阿斯科弗拉 (AF) 证明了Trypanosoma vivax感染的成功清除.
- 在清除Trypanosoma congolense感染方面,AF的疗效有限.
- 这项研究确定阿斯科弗拉作为T. vivax治疗的有希望的候选人.
结论:
- 阿斯科隆是牛中Trypanosoma vivax的潜在治疗剂.
- 建议进一步开发AF用于治疗T. vivax,特别是在非传染地区.
- 新药的研发对于对抗耐药性试类瘤的治疗至关重要.
相关概念视频
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...